 NEW YORK, Nov. 12, 2020 PRNewswire -- Rowley Law PLLC is investigating potential securities law violations by Akers Biosciences, Inc. NASDAQ: AKER and its board of directors concerning the proposed merger of the company with MyMD Pharmaceuticals, Inc. Akers Biosciences stockholders... 